LeeMKrugMD

Clinical Trials

• 10-Propargyl-10-Deazaaminopterin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer Start of enrollment: 1999 Jul 01

  Completed

  Phase 2

• Vaccine Therapy Plus QS21 in Treating Patients With Small Cell Lung Cancer That Has Responded to Initial Therapy Start of enrollment: 1998 Aug 01

  Completed

  Phase 2

• Vaccine Therapy and Sargramostim in Treating Patients With Non-small Cell Lung Cancer Start of enrollment: 1999 Jul 01

  Completed

  Phase 1

• Ecteinascidin 743 in Treating Patients With Malignant Mesothelioma Start of enrollment: 2001 Jul 01

  Terminated

  Phase 2

• Imatinib Mesylate and Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer Start of enrollment: 2002 Jul 01

  Completed

  Phase 1

• A Multicenter Phase II Trial of Neo-Adjuvant Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation for Pleural Mesothelioma Start of enrollment: 2003 Jul 01
• Monoclonal Antibody Therapy in Treating Patients With Progressive Small Cell Lung Cancer (SCLC) Start of enrollment: 2004 Jul 26

  Completed

  Phase 1

• Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma Start of enrollment: 2006 Oct 01

  Completed

  Phase 1

• Cisplatin or Carboplatin, and Etoposide With or Without Sunitinib Malate in Treating Patients With Extensive-Stage Small Cell Lung Cancer Start of enrollment: 2007 Mar 15

  Completed

  Phase 1, Phase 2

• Obatoclax Mesylate and Topotecan Hydrochloride in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer or Advanced Solid Tumors Start of enrollment: 2007 Aug 01

  Completed

  Phase 1, Phase 2

• Continuation Clinical Trial of Oral L-0010790038 in Advanced Cancer Start of enrollment: 2005 Aug 01
• Pleurectomy/Decortication (Neo) Adjuvant Chemotherapy and Intensity Modulated Radiation Therapy to the Pleura in Patients With Locally Advanced Malignant Pleural Mesothelioma Start of enrollment: 2008 Oct 11

  Active, not recruiting

  Phase 2

• Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity Start of enrollment: 2009 Dec 01

  Completed

  Phase 2

• WT-1 Analog Peptide Vaccine in Malignant Pleural Mesothelioma After Combined Modality Therapy Start of enrollment: 2010 Dec 21

  Completed

  Phase 2

• Immunization With a Pentavalent Vaccine Composed of KLH-conjugates of GD2L, GD3L, Globo H, Fucosyl GM1, and N-Propionylated Polysialic Acid Start of enrollment: 2011 May 01

  Completed

  Phase 1

• Psychosocial Needs and Exploration of Online Support for Patients With Mesothelioma Start of enrollment: 2011 May 01

  Completed

  Not Applicable

• Do Your Genes Put You at a Higher Risk of Developing Mesothelioma Start of enrollment: 2011 Jun 01

  Completed

• Nintedanib in Treating Patients With Malignant Pleural Mesothelioma That Is Recurrent Start of enrollment: 2016 Mar 15

  Completed

  Phase 2

• Join now to see all